3StocksOnFire — US Stock Trading Community · 451+ trades · 257% returns · 15,000 members · Main Site · Trader's Guide · Articles · Video Analyses
3 Stocks On Fire
3StocksOnFire Community Forum
Home Message Boards Trader's Guide Articles Video Analysis About Us Search Register

News:

Welcome to 3StocksOnFire! US stock trading community (2005-2010) with 451+ documented trades and 15,000+ members. View Portfolios | Stock Articles | Quotes

Main Menu

SVNT

Started by stocky, June 10, 2005, 12:30:48 AM

Previous topic - Next topic

stocky

Watch it.

setravis

Lows are history.
Great value with a successful turnaround in progress.
Would like to see it catch with some more volume.

http://stockcharts.com/def/servlet/SC.web?c=svnt
"Success loves to hide behind challenges.
Embrace the challenge, enjoy the journey."

Do your own DD and invest based on your DD, not mine !

Semper Fi
S.E.Travis

stocky

Yes true. Though today it was 1.5x Avg Volume. May be we see some more action next week. Dont have a position in it yet.

setravis

Stocky, in your oppinion.
Is that there a cup with handle pattern?
"Success loves to hide behind challenges.
Embrace the challenge, enjoy the journey."

Do your own DD and invest based on your DD, not mine !

Semper Fi
S.E.Travis

stocky

My technical analysis skills are very raw, so I wont be in a position to comment on it. However, due to the biotech conference next week, most of the biotech/pharma camp is bullish. Plus the trend with SVNT is on the up. If the volume shows up you can flow with the tide. Also to me it looks like a good stock with decent fundamentals. However all biotech/pharma stocks are more risky then the high octane tech stocks. So caution needed.

I have not taken any position in SVNT yet. Waiting for volume and gauging the NASDAQ direction in general.

Adam

I just bought in at 4.64, breaking out of a consolidation

REALDEALS21

Savient shares rise on commercial operations restructuring

Del.icio.us
By Gabriel Madway
Last Update: 11:38 AM ET Jan 8, 2007

SAN FRANCISCO (MarketWatch) -- Savient Pharmaceuticals Inc. (SVNT :
savient pharmaceuticals inc com


SVNT13.42, +0.68, +5.3% ) shares rose 7.8% to $12.57 in Monday morning trade after the East Brunswick, N.J.-based company announced late Friday that, as part of its restructuring of its commercial operations, it will discontinue its 19-person Oxandrin field sales force. The move follows the company's launch of oxandrolone, the generic version of Oxandrin.  ;D

basonista

Moving higher once again.

A couple of SVNT threads to merge, if you wouldn't mind setravis.  ;)